Skip to main content
Clinical Trials/JPRN-jRCTs072200039
JPRN-jRCTs072200039
Active, not recruiting
Phase 2

Evaluation of safety and effectiveness of cryoablation in the treatment of renal angiomyolipoma related to tuberous sclerosis complex - Cryo-tsc Study

Eto Masatoshi0 sites15 target enrollmentOctober 1, 2020

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
renal angiomyolipoma associated with tuberous sclerosis
Sponsor
Eto Masatoshi
Enrollment
15
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Eto Masatoshi

Eligibility Criteria

Inclusion Criteria

  • 1\.A patient over 16 years old at the time of obtaining consent
  • 2\.A patient with a definitive diagnosis of tuberous sclerosis according to the modified Gomez criteria or the TSC Clinical Consensus Guideline for Diagnosis 2012 at the time of registration
  • 3\.A patient with an independent AML on imaging within 4months before enrollment measuring greater than 1 cm and less than 4 cm in long axis as the treatment target, regardless of prsence or absence of mTOR inhibitor treatment
  • 4\.Informed consent has been obtained from one of the following:
  • 1\)The patient only (if the patient is over 20 years old and can fully understand the explanation)
  • 2\)The patient and his / her substitute (parent, guardian, etc.) (if the patient is under 20 years old and can fully understand the explanation)
  • 3\)Legal guardian only (if the patient is judged to lack the ability to make a decision regarding the conduct of the study)

Exclusion Criteria

  • 1\.A patient who cannot interrupt mTOR inhibitor treatment
  • 2\.A patient who cannot keep still during cryotherapy
  • 3\.A patient with platelets less than 6X10^4/uL(within 28 days before registration)
  • 4\.A patient with a history of serious allergies to contrast agents and / or embolic substances
  • 5\.A patient with infection requiring systemic treatment
  • 6\.A patient with malignant tumor
  • 7\.A woman who is pregnant, possibly pregnant or within 28 days after delivery
  • 8\.A patient who has a mental illness or psychiatric disorder that interferes with daily life, such that participation in the study is considered difficult
  • 9\.A patient with uncontrolled hypertension
  • 10\.A patient who is otherwise assessed as inappropriate by the doctor in charge

Outcomes

Primary Outcomes

Not specified

Similar Trials